Bank, Steffen <br/><br/>
Polymorphisms in the NFkB, TNF-alpha, IL-1beta, and IL-18 pathways are associated with response to anti-TNF therapy in Danish patients with inflammatory bowel disease.  [electronic resource] 

 -  Alimentary pharmacology & therapeutics  04 2019 
 - 890-903 p.  digital 
<br/><br/> Publication Type: Journal Article; Research Support, Non-U.S. Gov't 
<br/><br/><label>ISSN: </label>1365-2036 
<br/><br/><label>Standard No.: </label>10.1111/apt.15187  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Adolescent<br/>Adult<br/>Aged<br/>Aged, 80 and over<br/>Child<br/>Child, Preschool<br/>Cohort Studies<br/>Denmark--epidemiology<br/>Female<br/>Humans<br/>Inflammatory Bowel Diseases--drug therapy<br/>Interleukin-18--genetics<br/>Interleukin-1beta--genetics<br/>Male<br/>Middle Aged<br/>NF-kappa B--genetics<br/>Polymorphism, Single Nucleotide--genetics<br/>Retrospective Studies<br/>Tumor Necrosis Factor Inhibitors--therapeutic use<br/>Tumor Necrosis Factor-alpha--genetics<br/>Young Adult